Semaglutide, better known by its brand name Ozempic, has been making headlines as a weight loss drug – despite only having FDA approval to treat diabetes. Now, some say it doesn’t just quell cravings for food – it helps quiet cravings for alcohol, drugs, and other compulsive behaviors. For years, researchers have been studying semaglutide's effectiveness as an addiction cure in animals. What have they found? And – does it actually work?
Guest: Sarah Zhang covers health and medicine for The Atlantic
If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Amicus—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work.
Hosted on Acast. See acast.com/privacy for more information.
